These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 19259097)

  • 61. The World Health Organization (WHO) classification of tumors of the hematopoietic and lymphoid tissues: an overview with emphasis on the myeloid neoplasms.
    Vardiman JW
    Chem Biol Interact; 2010 Mar; 184(1-2):16-20. PubMed ID: 19857474
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Autoimmune diseases, asthma and risk of haematological malignancies: a nationwide case-control study in Sweden.
    Söderberg KC; Jonsson F; Winqvist O; Hagmar L; Feychting M
    Eur J Cancer; 2006 Nov; 42(17):3028-33. PubMed ID: 16945522
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Spectrum of associated clonal hematologic non-mast cell lineage disorders occurring in patients with systemic mastocytosis.
    Sperr WR; Horny HP; Valent P
    Int Arch Allergy Immunol; 2002 Feb; 127(2):140-2. PubMed ID: 11919425
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Loss of 5q in myeloid malignancies - A gain in understanding of biological and clinical consequences.
    Venugopal S; Mascarenhas J; Steensma DP
    Blood Rev; 2021 Mar; 46():100735. PubMed ID: 32736878
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Assessing Symptom Burden in Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Patients.
    Garza J; Anderson JM; Scherber RM
    Hematol Oncol Clin North Am; 2020 Apr; 34(2):475-489. PubMed ID: 32089224
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Lymphoblastic leukemia following myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms.
    Xie W; Chen Z; Wang SA; Hu S; Li S; Miranda RN; Medeiros LJ; Tang G
    Leuk Lymphoma; 2019 Dec; 60(12):2993-3001. PubMed ID: 31017498
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Treatment of progression of Philadelphia-negative myeloproliferative neoplasms to myelodysplastic syndrome or acute myeloid leukemia by azacitidine: a report on 54 cases on the behalf of the Groupe Francophone des Myelodysplasies (GFM).
    Thepot S; Itzykson R; Seegers V; Raffoux E; Quesnel B; Chait Y; Sorin L; Dreyfus F; Cluzeau T; Delaunay J; Sanhes L; Eclache V; Dartigeas C; Turlure P; Harel S; Salanoubat C; Kiladjian JJ; Fenaux P; Adès L;
    Blood; 2010 Nov; 116(19):3735-42. PubMed ID: 20664061
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Prevalence of autoimmune diseases in in-patients with schizophrenia: nationwide population-based study.
    Chen SJ; Chao YL; Chen CY; Chang CM; Wu EC; Wu CS; Yeh HH; Chen CH; Tsai HJ
    Br J Psychiatry; 2012 May; 200(5):374-80. PubMed ID: 22442099
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Role of innate immune signaling and inflammation in the pathogenesis of myeloid malignancies].
    Muto T
    Rinsho Ketsueki; 2023; 64(9):962-969. PubMed ID: 37793872
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Antecedent cardiovascular disease and autoimmunity in Philadelphia-negative chronic myeloproliferative neoplasms.
    Sørensen AL; Hasselbalch HC
    Leuk Res; 2016 Feb; 41():27-35. PubMed ID: 26718091
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Expanding the role of the splicing USB1 gene from Poikiloderma with Neutropenia to acquired myeloid neoplasms.
    Negri G; Crescenzi B; Colombo EA; Fontana L; Barba G; Arcioni F; Gervasini C; Mecucci C; Larizza L
    Br J Haematol; 2015 Nov; 171(4):557-65. PubMed ID: 26306619
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cutaneous extramedullary hemopoiesis in chronic myeloproliferative and myelodysplastic disorders.
    Haniffa MA; Wilkins BS; Blasdale C; Simpson NB
    J Am Acad Dermatol; 2006 Aug; 55(2 Suppl):S28-31. PubMed ID: 16843120
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies.
    Darrington DL; Vose JM; Anderson JR; Bierman PJ; Bishop MR; Chan WC; Morris ME; Reed EC; Sanger WG; Tarantolo SR
    J Clin Oncol; 1994 Dec; 12(12):2527-34. PubMed ID: 7989926
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Long-term follow-up for up to 5 years on the risk of leukaemic progression in thrombocytopenic patients with lower-risk myelodysplastic syndromes treated with romiplostim or placebo in a randomised double-blind trial.
    Kantarjian HM; Fenaux P; Sekeres MA; Szer J; Platzbecker U; Kuendgen A; Gaidano G; Wiktor-Jedrzejczak W; Carpenter N; Mehta B; Franklin J; Giagounidis A
    Lancet Haematol; 2018 Mar; 5(3):e117-e126. PubMed ID: 29396092
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [The myelodysplastic syndrome and autoimmunity].
    Laursen SB; Nielsen MØ; Hasselbalch HC
    Ugeskr Laeger; 2009 Sep; 171(37):2639-42. PubMed ID: 19758507
    [TBL] [Abstract][Full Text] [Related]  

  • 76. MDS overlap disorders and diagnostic boundaries.
    Tanaka TN; Bejar R
    Blood; 2019 Mar; 133(10):1086-1095. PubMed ID: 30670443
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The incidence, risk factors, and survival of acute myeloid leukemia secondary to myelodysplastic syndrome: A population-based study.
    Ye X; Chen D; Zheng Y; Wu C; Zhu X; Huang J
    Hematol Oncol; 2019 Oct; 37(4):438-446. PubMed ID: 31378958
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Anthropometric factors and risk of myeloid leukaemias and myelodysplastic syndromes: a prospective study and meta-analysis.
    Teras LR; Patel AV; Carter BD; Rees-Punia E; McCullough ML; Gapstur SM
    Br J Haematol; 2019 Jul; 186(2):243-254. PubMed ID: 30977126
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Prognostic markers for myeloid neoplasms: a comparative review of the literature and goals for future investigation.
    Juopperi TA; Bienzle D; Bernreuter DC; Vernau W; Thrall MA; McManus PM
    Vet Pathol; 2011 Jan; 48(1):182-97. PubMed ID: 21139142
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Acute myeloid leukemia and myelodysplastic syndrome after adjuvant chemotherapy: A population-based study among older breast cancer patients.
    Rosenstock AS; Niu J; Giordano SH; Zhao H; Wolff AC; Chavez-MacGregor M
    Cancer; 2018 Mar; 124(5):899-906. PubMed ID: 29236294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.